Stock változás Dátum
Acadia Pharmaceuticals USD 35.82M 15.05M 2023-12
Agios Pharmaceuticals USD 8.49M 3.32M 2022-12
Alnylam Pharmaceuticals USD 89.15M 6.62M 2023-12
Amgen USD 9.52B 4.49B 2023-12
Biogen USD 2.53B 455M 2023-12
BioMarin Pharmaceutical USD 894.08M 54.62M 2022-12
Bluebird Bio USD 20.97M 7.33M 2023-09
Bristol-Myers Squibb USD 2.44B 72M 2023-09
Eli Lilly USD 4.31B 478.6M 2022-12
Exelixis USD 17.32M 7.65M 2023-12
Gilead Sciences USD 3.37B 1.7B 2023-12
Incyte USD 62.97M 5.77M 2023-12
Ionis Pharmaceuticals USD 28.42M 2.79M 2023-12
MacroGenics USD 1.45M 365K 2022-12
Merck USD 5.91B 297M 2022-12
Moderna USD 202M 285M 2023-12
Nektar Therapeutics USD 19.2M 145K 2022-12
Neurocrine Biosciences USD 28.8M 2.9M 2023-09
Novartis USD 7.18B 396M 2022-12
Novartis USD 6.67B 465M 2021-12
Pfizer USD 8.98B 532M 2022-12
PTC Therapeutics USD 21.81M 7M 2022-12
Regeneron Pharmaceuticals USD 2.58B 18.5M 2023-12
Sarepta Therapeutics USD 244.01M 17.13M 2023-09
Ultragenyx Pharmaceutical USD 31.8M 3.55M 2023-09
Vertex Pharmaceuticals USD 738.8M 50.1M 2023-12



Incyte Készlet - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2024.